CB2 Insights Announces Annual General & Special Meeting of Shareholders and Corporate Update

Ads

You May Also Like

BriaCell Publishes Clinical Findings in 2018 American Society of Clinical Oncology (ASCO) Meeting

BERKELEY, Calif. and VANCOUVER, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics ...

NANOBIOTIX : FDA approves Nanobiotix’s first Immuno-Oncology trial

  FDA APPROVES NANOBIOTIX'S FIRST IMMUNO-ONCOLOGY TRIAL:A PHASE I/II STUDY OF NBTXR3 ACTIVATED BY ...